Inside the science
How AlloBiome Works
1
Discover your bloating type:
Identify with a symptom pattern.
The quiz identifies the pattern that matches the digestive experience.
Each pattern reflects trends observed in microbiome research.
The program then organizes evidence-based education around that pattern.
2
Three Research–Based Phases
The full program delivers curated scientific content week by week, organized into 3 phases so the information arrives progressively.
Phase 1: Remove (Weeks 1–8)
Current research on natural methods to rebalance the gut, focusing on plant-based antimicrobials and digestive support.
Phase 2: Rebuild (Weeks 9–12)
Scientific findings on specialized probiotics, beneficial yeast, and nutrients that support gut resilience.
Phase 3: Maintain (Weeks 13–16)
Research-based strategies for ongoing support, diet expansion, and health-promoting habits.
3
Build Awareness with a Daily Symptom Log
A daily symptom diary runs alongside the program as an awareness-building tool. It helps develop a clearer understanding of personal digestive patterns over time.
Tracking daily responses to food, stress, sleep, and other factors creates a picture of what influences digestive comfort, making the scientific content from the program more relevant and easier to apply.
✓
Science–Backed.
✓
Research–Driven.
✓
Easy to Understand.
The research behind each phase
Phase 1: Remove
A randomized controlled trial with over 400 participants found that berberine significantly alters gut microbiome composition, reducing harmful microbial activity while supporting beneficial populations. A comprehensive revie confirms berberine increases short-chain fatty acid producers like Butyricimonas and Ruminococcus while reducing opportunistic pathogens. Studies combining herbal antimicrobials with biofilm disruptors show significantly greater reductions in gas levels compared to herbal compounds alone. The active compounds in oregano and thyme, particularly carvacrol, disrupt bacteria cell membranes, interfere with bacterial communication, and inhibit biofilm formation in the gut, while leaving beneficial bacteria largely intact.
Zhang Y et al. Nature Communications. 2020/Zhang et al. Frontiers in Cellular and Infection Microbiology. 2021 / Ruscio et al. Cureus. 2025 / Moghrovyan & Sahakyan.
AIMS Biophysics. 2024
A 2014 Landmark
Science has known since 2014 that herbal antimicrobials perform comparably to pharmaceutical antibiotics in resolving microbiome imbalances, and subsequent studies have continued to confirm it.
Chedid et al. Global Advances in Health and Medicine. 2014
Phase 2: Rebuild
Once the gut environment shifts, rebuilding happens on three fronts simultaneously. Spore-based probiotics have been shown to increase the diversity of beneficial bacteria and support the production of compounds that feed the gut lining. Research shows that L-glutamine restores tight junction protein expression in the intestinal lining, while zinc carnosine provides direct mucosal protection through antioxidative and membrane-stabilizing mechanisms, strengthening the gut barrier from two distinct pathways. Research on ginger and artichoke extracts shows they significantly improve gut motility, helping food and bacteria move through the digestive tract the way they should, which is essential for keeping the gut environment stable after the first phase.
Marzorati et al. Food Research International. 2021 / Zhou et al. Gut. 2019 / Efthymakis & Neri. Clinical Research in Hepatology and Gastroenterology. 2022 / Drobnic et al.
Minerva Gastroenterology. 2022
Phase 3: Maintain
Sustaining microbiome balance requires expanding diversity, not maintaining a fixed protocol. A 17-week randomized study found that consistently eating fermented foods steadily increased microbiome diversity and reduced 19 inflammatory markers over time. Data from two large prospective cohorts confirm that greater variety across plant food groups is independently associated with higher gut microbiome diversity, which is why rotating fiber types like resistant starches, inulin-type fructans, and beta-glucans matters: each feeds distinct bacterial populations that a single source cannot reach. A systematic review of 13 human studies found that psychological stress is consistently associated with significant reductions in specific beneficial bacterial groups at the genus level, making lifestyle consistency as important as any dietary input in preserving what the earlier phases built.
Wastyk et al. Cell. 2021 / Xiao et al. American Journal of Clinical Nutrition. 2022/ Ma et al. Neuropsychobiology. 2023
Got questions? We have answers
Who is the AlloBiome program for?
AlloBiome is for people who experience chronic bloating, irregular digestion, or other persistent gut symptoms and want to understand what science currently knows about those patterns. This is not a medical service and does not replace professional care. It is a science education resource for people who are tired of generic advice and want real answers backed by real research.
What is microbiome pattern education?
It is not a course or a class. It is a living body of scientific knowledge, continuously synthesized from thousands of peer-reviewed studies by Al and reviewed by the NEIMS research team. The content goes far beyond surface-level information. It covers fermentation dynamics, motility research, gut ecosystem science, and what current studies say about specific supplements, including the evidence behind doses, timing, and ingredient quality. The NEIMS team has the tools and infrastructure to evaluate brands and ingredients properly, so the science presented reflects what is actually supported in the literature, not just what is marketed well.
How does the daily symptom diary work?
The diary is an awareness tool, not a treatment tracker. It helps build a clearer picture of personal digestive patterns over time by observing how symptoms relate to food, stress, sleep, and other factors. AlloBiome does not interpret diary data or provide any form of assessment or guidance based on it.
Does AlloBiome address other digestive patterns?
The current program focuses on the pattern identified through the quiz. The NEIMS research team continuously reviews emerging research, and additional educational content may be added as the science develops.
How is the program content delivered?
Content is released week by week across three phases: Remove, Rebuild, and Maintain. This is not a passive library to scroll through. The
progressive structure ensures the information arrives when it is most relevant, covering what researchers currently know about each phase of gut recovery, from antimicrobial compounds and biofilm disruption to probiotic strains, gut lining support, and long-term microbiome maintenance. Everything is broken down so it is easy to absorb and relevant to where someone actually is in their learning.
How long is the program ?
The program spans 16 weeks across three phases, with the final phase designed as an ongoing practice. The goal is long-term understanding, not a quick fix.
References
- Zhang, Y., Gu, Y., Ren, H., Wang, S., Zhong, H., Zhao, X., … & Jia, W. (2020). Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nature Communications, 11, 5015. https://doi.org/10.1038/s41467-020-18414-8
- Zhang, L., Wu, X., Yang, R., Chen, F., Liao, Y., Zhu, Z., Wu, Z., Sun, X., & Wang, L. (2021). Effects of Berberine on the Gastrointestinal Microbiota. Frontiers in Cellular and Infection Microbiology, 10, 588517. https://doi.org/10.3389/fcimb.2020.588517
- Moghrovyan, A., & Sahakyan, N. (2024). Antimicrobial activity and mechanisms of action of Origanum vulgare L. essential oil: effects on membrane-associated properties. AIMS Biophysics, 11(4), 508-526. https://doi.org/10.3934/biophy.2024027
- Chedid, V., Dhalla, S., Clarke, J. O., Roland, B. C., Dunbar, K. B., Koh, J., Justino, E., Tomakin, E., & Mullin, G. E. (2014). Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Global Advances in Health and Medicine, 3(3), 16-24. https://doi.org/10.7453/gahmj.2014.019
- Ruscio, M., Lukens, B., & D’Adamo, C. R. (2025). Biofilm disruption combined with herbal antimicrobials in small intestinal bacterial overgrowth. Cureus. https://doi.org/10.7759/cureus
- Marzorati, M., Van den Abbeele, P., Bubeck, S., Bayne, T., Krishnan, K., & Young, A. (2021). Treatment with a spore-based probiotic containing five strains of Bacillus induced changes in the metabolic activity and community composition of the gut microbiota in a SHIME model. Food Research International, 149, 110676. https://doi.org/10.1016/j.foodres.2021.110676
- Zhou, Q., Verne, M. L., Fields, J. Z., Lefante, J. J., Basra, S., Salameh, H., & Verne, G. N. (2019). Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. Gut, 68(6), 996-1002. https://doi.org/10.1136/gutjnl-2017-315136
- Efthymakis, K., & Neri, M. (2022). The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review. Clinics and Research in Hepatology and Gastroenterology, 46(7), 101954. https://doi.org/10.1016/j.clinre.2022.101954
- Drobnic, F., Fonts, S., García-Alday, I., Petrangolini, G., Riva, A., Frattini, E., Allegrini, P., Togni, S., & Vitale, J. (2022). Efficacy of artichoke and ginger extracts with simethicone to treat gastrointestinal symptoms in endurance athletes: a pilot study. Minerva Gastroenterologica (Torino), 68(1), 77–84. https://doi.org/10.23736/S2724-5985.20.02664-1
- Wastyk, H. J., Fragiadakis, G. K., Perelman, D., Dahl, W. J., Merrill, B. D., Yu, F. B., Topf, M., Gonzalez, J. G., Van Treuren, W., Hahn, S., Robinson, J. L., Elias, J. E., D. D., Ener, D. Garner, & D. Son. Sonnenburg, J. L. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137- 4153.e14. https://doi.org/10.1016/j.cell.2021.06.019
- Ma, L., Yan, Y., Webb, R. J., Li, Y., Mehrabani, S., Xin, B., Sun, X., Wang, Y., & Mazidi, M. (2023). Psychological stress and gut microbiota composition: a systematic review of human studies. Neuropsychobiology, 82(5), 247-262. https://doi.org/10.1159/000533131
- Xiao, C., Wang, J. T., Su, C., Miao, Z., Tang, J., Ouyang, Y., Yan, Y., Jiang, Z., Fu, Y., Shuai, M., Gou, W., Xu, F., Yu, E. Y. W., Liang, Y., Liang, X., Tian, Y., Wang, J., Huang, F., Zhang, B., Wang, H., Chen, Y. M., & Zheng, J. S. (2022). Associations of dietary diversity with the gut microbiome, fecal metabolites, and host metabolism: results from 2 prospective Chinese cohorts. American Journal of Clinical Nutrition, 116(4), 1049-1058. https://doi.org/10.1093/ajcn/nqac178